JDD September Issue Highlights
Here are the highlights from the September issue of JDD!
For African American women, concerns about facial aging may be more about pigmentary concerns and shifts in underlying soft tissue volume in Understanding the Female African American Facial Aesthetic Patient.
Authors evaluate long-term safety and efficacy of ATX-101 for submental fat reduction in ATX-101 (Deoxycholic Ac …
Here are the highlights from the September issue of JDD!
For African American women, concerns about facial aging may be more about pigmentary concerns and shifts in underlying soft tissue volume in Understanding the Female African American Facial Aesthetic Patient.
Authors evaluate long-term safety and efficacy of ATX-101 for submental fat reduction in ATX-101 (Deoxycholic Ac …







All of the following are true regarding the condition pictured EXCEPT:
A. Perilesional direct immunofluroescence shows granular IgA in the dermal papillae and at the dermoepidermal junction.
B. Only 20% of patients have a gluten-sensitive enteropathy.
C. It is associated with HLA-DQ2, HLA-DR3, and HLA-B8.
D. It is associated with Hashimoto's thyroiditis.
E. Cutaneous findings ar …
During the month of September, Next Steps in Derm Ask the Expert segment gives you access to Dr. Joshua Zeichner, Director of Cosmetic and Clinical Research in Dermatology at Mount Sinai Hospital in New York City. Dr. Zeichner is one of the country's key opinion leaders in treating acne and is an expert in cosmeceuticals and skin care.
If you have questions for Dr. Zeichner on any of his area …
This month’s Patient Buzz includes warnings for consumers: Fake facial fillers for sale online. A recall of a popular at-home light therapy mask. An acne treatment promoted by a celebrity that may irritate the skin.
Be prepared for the questions your patients may ask by perusing this list of dermatology news from the consumer press:
Allure: Fake facial fillers
Allure: Scalp acne
Bu …
Abstract
Botulinum toxin type A (BTA) is a neurotoxic protein that prevents the release of neurotransmitters from presynaptic nerves and has shown promise in treating neuropathic pain. Recently, BTA has been used to treat painful keloids and scars. We present a patient with refractory neuropathic pain in a normotrophic spread-scar treated with the injection of BTA.
A 47-year-old Caucasian female …